Crohn’s

Discovered interaction between bacteria and immune cells protects the intestinal barrier

An international study led by the Complutense University of Madrid (UCM) and the National Centre for Cardiovascular Research (CNIC) has found that Lactobacillusbacteria present in the intestinal microbiota interact with immune system cells to strengthen the intestinal barrier. Conducted on mice and published in Immunity, the study opens a new avenue for the treatment of diseases such as ulcerative colitis or Crohn’s ...

Read More »

Study to compare the effectiveness of biologic or small molecule therapies in IBD receives funding

Crohn’s disease (CD) and ulcerative colitis (UC), collectively referred to as inflammatory bowel diseases (IBD), which may affect as many as 3 million Americans, cost over $6 billion annually, and cause substantial patient morbidity, missed work and school, and diminished quality of life. Currently, anti-TNF therapy is considered first line treatment for moderate-to-severe IBD. However, up to 80 percent of ...

Read More »

New methods for genetics analyses and diagnosis of inflammatory bowel disease

The two most common types of inflammatory bowel diseases are ulcerous colitis and Crohn’s disease. These are diagnosed by camera inside the gut, and by investigating small samples of the gut (biopsies). The diagnosis is often difficult, and if the wrong diagnosis is made, there may be severe consequences for the patients, because the treatments and medications are different between ...

Read More »

AGA Launches New Patient App to Aid in Inflammatory Bowel Disease (IBD) Monitoring and Education

The American Gastroenterological Association (AGA) today announced the launch of My IBD Manager, a new digital patient resource developed for the 1.6 million Americans living with Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), and the doctors who treat them. This will be followed by the launch of an online clinical platform for health care professionals, ...

Read More »

Crohn’s & Colitis Foundation Launches New IBD Clinical Trials Community to Educate and Support Clinical Trial Participation

Clinical trial recruitment is a challenging step toward FDA approval of new treatments for patients across all disease states; this is especially true for inflammatory bowel diseases (IBD). The Crohn’s & Colitis Foundation (the Foundation) launched today a dedicated Clinical Trials Community (the Community) for IBD. The Community is designed to educate patients, caregivers, and healthcare providers about the clinical ...

Read More »